Skip to content

Propolis on human health: their role on oxidative stress and lipid metabolism a randomized clinical trial

“Mejoramiento de la competitividad del sector apícola a partir de la diversificación de productos y su evaluación como aporte a la salud del Maule.”

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160114001
Enrollment
65
Registered
2016-01-14
Start date
2014-03-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subject with metabolic disorders such cardiovascular disease&#44

Interventions

. The eligible subjects were randomized in two groups. One consumed propolis (n=35) and the other one (n=32) consume a placebo with same flavors and appearance than propolis (a mixture of peppermint a
45 and 90 days&#44
also they were controlled by phone interview&#44
focus group and personal interview along the study. All the analysis was made at day zero and ninety.
Propolis in human health

Sponsors

Fondos para la Innovación de la Competitividad (FIC) Maule Nº BIP.30.136.439-0
Lead Sponsor
Fondos para la Innovación de la Competitividad (FIC) Maule Nº BIP.30.136.439&#45
Collaborator
0 and Rotterdam Labo
Collaborator

Eligibility

Sex/Gender
All
Age
0 Years to 0 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were: (1) age > 18 and < 69 years&#44; (2) to have at least one of the following altered parameters: fast glycaemia&#44; lipids profile&#44; blood pressure&#44; and/or over weight. To have some metabolism disorders like: diabetes mellitus&#44; and cardiovascular disease.

Exclusion criteria

Exclusion criteria: The exclusion criteria were: (i) history of significant alcohol consumption; (ii) background of any known important acute or chronic pathological conditions such liver and/or renal failure&#44; immunological disorders&#44; VIH&#44; cancer&#44; among others); (iii) unlikely to cooperate with the study regime. During the study 8 subjects were voluntary retired and 3 additional were excluded by have the insulinaemia over normal range (> 100 µU /mL).

Design outcomes

Primary

MeasureTime frame
Propolis diversity use in human health 6 months case&#45;control&#44; randomized&#44; double blind&#44; placebo controlled

Secondary

MeasureTime frame
Propolis in human health 6 months case&#45;control&#44; randomized&#44; double blind&#44; placebo controlled

Countries

Chile

Contacts

Public ContactElba Leiva

Universidad de Talca

eleivam@utalca.cl56-9-90793841

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026